Barbara Ann Karmanos Cancer Institute-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Barbara Ann Karmanos Cancer Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011925
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Barbara Ann Karmanos Cancer Institute (Karmanos), a subsidiary of McLaren Health Care Corp is a healthcare institute that provides patient care and educational services. The institute offers patient care for the prevention, early detection, treatment and eventual eradication of cancer. Its cancer care programs comprise treatment options and side effects, clinical trials, radiology services, women’s wellness center, breast and cervical cancer control program, cord blood program, national asbestos-vermiculite center. The institute provides imaging services such as digital screening and diagnostic mammography; diagnostic ultrasound, PET, CT and MRI services; molecular breast imaging; general diagnostic radiology services; and cryoablation for benign fibroadenomas, among others. Karmanos is headquartered in Detroit, Michigan, the US.

Barbara Ann Karmanos Cancer Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
CureMeta Enters into Research Agreement with Barbara Ann Karmanos Cancer Institute 11
Asset Transactions 12
Residential Home Health Acquires Karmanos Hospice From Karmanos Cancer Institute 12
Acquisition 13
McLaren Health Care To Acquire Karmanos 13
Barbara Ann Karmanos Cancer Institute – Key Competitors 15
Barbara Ann Karmanos Cancer Institute – Key Employees 16
Barbara Ann Karmanos Cancer Institute – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
May 23, 2017: Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium 18
Other Significant Developments 19
Jan 11, 2017: Karmanos Cancer Institute joins nation’s leading cancer centers to endorse HPV vaccine 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Key Facts 2
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Barbara Ann Karmanos Cancer Institute, Deals By Therapy Area, 2011 to YTD 2017 8
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
CureMeta Enters into Research Agreement with Barbara Ann Karmanos Cancer Institute 11
Residential Home Health Acquires Karmanos Hospice From Karmanos Cancer Institute 12
McLaren Health Care To Acquire Karmanos 13
Barbara Ann Karmanos Cancer Institute, Key Competitors 15
Barbara Ann Karmanos Cancer Institute, Key Employees 16
Barbara Ann Karmanos Cancer Institute, Other Locations 17

★海外企業調査レポート[Barbara Ann Karmanos Cancer Institute-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Plexus Corp (PLXS):企業の財務・戦略的SWOT分析
    Plexus Corp (PLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kina Petroleum Ltd (KPL)-石油・ガス分野:企業M&A・提携分析
    Summary Kina Petroleum Limited (KPL) is an upstream oil and gas company that focuses on exploration, development and production activities. It has operations in Papua New Guinea (PNG) and Australia. The company focuses on participating in highly prospective oil and gas acreage positions near to prov …
  • The Blackstone Group LP:企業の戦略・SWOT・財務情報
    The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report Summary The Blackstone Group LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Intrasense SA (ALINS):医療機器:M&Aディール及び事業提携情報
    Summary Intrasense SA (Intrasense) is a healthcare technology company that offers software solution for analysis and visualisation of medical images. The company provides a range of clinical apps such as lesion tracking solution, analysis tools, virtual colonoscopy, and lung nodule follow-up softwar …
  • Financial and Strategic SWOT Analysis Review
    Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportuni …
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • genedrive plc (GDR)-製薬・医療分野:企業M&A・提携分析
    Summary genedrive plc (genedrive), formerly Epistem Holdings plc is a molecular diagnostics company. The company focuses on the development and commercialization of simple to use “point of need” system or point of care diagnostics platform for the diagnosis of infectious diseases and use in patient …
  • Origin Energy Ltd (ORG):電力:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • Five Prime Therapeutics Inc (FPRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Five Prime Therapeutics Inc (Five Prime) is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic protei …
  • The Kansai Electric Power Company Inc:発電所・企業SWOT分析
    The Kansai Electric Power Company Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • PRA Health Sciences Inc (PRAH):医療機器:M&Aディール及び事業提携情報
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometri …
  • AA PLC:企業の戦略・SWOT・財務分析
    AA PLC - Strategy, SWOT and Corporate Finance Report Summary AA PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Nanosonics Ltd (NAN):製薬・医療:M&Aディール及び事業提携情報
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • Sahacogen (Chonburi) Public Company Limited (SCG):企業の財務・戦略的SWOT分析
    Sahacogen (Chonburi) Public Company Limited (SCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • EnergySolutions, Inc.:企業の戦略・SWOT・財務情報
    EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary EnergySolutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China Meheco Co Ltd:企業の戦略・SWOT・財務情報
    China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Meheco Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Palatin Technologies Inc (PTN):製薬・医療:M&Aディール及び事業提携情報
    Summary Palatin Technologies Inc (Palatin) is a biopharmaceutical company that undertakes the development of targeted, receptor-specific peptide therapeutics. The company’s development programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor sys …
  • Teachers Insurance and Annuity Association of America (TIAA):企業のM&A・事業提携・投資動向
    Teachers Insurance and Annuity Association of America (TIAA) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teachers Insurance and Annuity Association of America (TIAA) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report …
  • ICON Plc (ICLR):企業の財務・戦略的SWOT分析
    ICON Plc (ICLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Ackermans & Van Haaren NV:戦略・SWOT・企業財務分析
    Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report Summary Ackermans & Van Haaren NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆